JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds
Signaling Pathways

Signaling Pathways

A8254 SB 203580
38 Citation

Target: p38|PKB

Summary: P38 MAP kinase inhibitor

insoluble in H2O; ≥18.872 mg/mL
A2917 Flumazenil
1 Citation

Target: GABAA Receptors

Summary: Benzodiazepine antagonist

insoluble in H2O; insoluble in EtOH; ≥30.38 mg/mL
A1984 Bendamustine HCl

Summary: Cytostatic agent for non-Hodgkin lymphomas
A2813 Ivermectin
2 Citation

Summary: NAChR/purinergic P2X4 receptor modulator

≥43.75 mg/mL
A1877 XAV-939
16 Citation

Target: TNKS

Summary: Tankyrase 1/2 (TNKS) inhibitor

insoluble in H2O; insoluble in EtOH; ≥15.62 mg/mL
A2548 Carmofur

Summary: Cytostatic derivative of fluorouracilm,antineoplatic agent
A2097 Ifosfamide

Target: DNA Alkylating

Summary: Cytostatic agent

≥13.05 mg/mL
A1980 SNS-032 (BMS-387032)
2 Citation

Target: Cyclin-Dependent Kinases

Summary: CDK inhibitor

insoluble in H2O; ≥19.05 mg/mL
A1805 Imatinib Mesylate (STI571)
2 Citation

Target: PDGFR|c-Kit|Bcr-Abl

Summary: Abl/c-kit/PDGFR inhibitor

≥29.5 mg/mL
A1379 Nelarabine

Summary: Prodrug of ara-G for T-LBL/T-ALL

insoluble in EtOH; ≥14.85 mg/mL